Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma.

Neoplasma - 1 Nov 2021

Shi Yiping, Zha Qiongfang, Ye Qing, Xue Shan, Wu Huawei, Tang Daoqiang, Qin Hui, Zou Jing

Abstract excerpt

Detection of epidermal growth factor receptor (EGFR) is one real dilemma owing to the non-sufficient tissue for testing EGFR mutations in lung adenocarcinoma. A model for predicting EGFR mutations would be helpful for clinical decisions in those patients. A retrospective cohort of 1,196 patients diagnosed with lung adenocarcinoma was investigated between December 1, 2017, and December 31, 2019, in Renji Hospital,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genes, erbB-1

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 34689565
DOI: 10.4149/neo_2021_210425N567

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma.PMID 34689565Read ↗

Nomogram Based on Preoperative CT Imaging Predicts The EGFR Mutation Status in Lung AdenocarcinomaSemantic proximity Read ↗

Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels.Semantic proximity Read ↗

A predictive model of computed tomography and clinical features of EGFR gene mutation in lung adenocarcinoma.Semantic proximity Read ↗

Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.Semantic proximity Read ↗

Predicting EGFR Mutation in Lung Adenocarcinoma: Development and Validation of the EGFR Mutation Predictive Score (EMPS) in Bali, Indonesia.Semantic proximity Read ↗

Development and Validation of a Concise Prediction Scoring System for Asian Lung Cancer Patients with EGFR Mutation Before Treatment.Semantic proximity Read ↗

Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.Semantic proximity Read ↗

Clinical characteristics and establishment of a 2-year-OS predictive model of EGFR mutation-positive patients with pleural invasion of lung adenocarcinoma.Semantic proximity Read ↗

Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients.Semantic proximity Read ↗

Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.Semantic proximity Read ↗

[Results of EGFR Mutations Detected in Pleural Effusion and Its Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Study in A Single Center].Semantic proximity Read ↗

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.